KBTBD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.175800E-01
Normal-vs-Stage2
3.702400E-01
Normal-vs-Stage3
2.777000E-01
Normal-vs-Stage4
7.479400E-01
Stage1-vs-Stage2
1.413190E-01
Stage1-vs-Stage3
1.721440E-01
Stage1-vs-Stage4
2.905400E-01
Stage2-vs-Stage3
6.908400E-01
Stage2-vs-Stage4
5.411800E-01
Stage3-vs-Stage4
4.597400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.287600E-01
Normal-vs-AfricanAmerican
5.747400E-01
Normal-vs-Asian
1.367220E-01
Caucasian-vs-AfricanAmerican
7.868800E-01
Caucasian-vs-Asian
5.266000E-02
AfricanAmerican-vs-Asian
4.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.039000E-01
Normal-vs-Female
7.721200E-01
Male-vs-Female
9.936000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.287000E-01
Normal-vs-Age(41-60Yrs)
9.541800E-01
Normal-vs-Age(61-80Yrs)
6.690600E-01
Normal-vs-Age(81-100Yrs)
3.051800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.140800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.470600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.423000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.113200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.118600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.062200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.359900E-02
Normal-vs-Daily Drinker
4.949600E-01
Normal-vs-Weekly Drinker
1.441830E-01
Normal-vs-Occasional Drinker
8.490600E-01
Normal-vs-Social Drinker
9.449000E-01
Non Drinker-vs-Daily Drinker
5.124800E-01
Non Drinker-vs-Weekly Drinker
4.144000E-01
Non Drinker-vs-Occasional Drinker
3.117700E-02
Non Drinker-vs-Social Drinker
1.551210E-01
Daily Drinker-vs-Weekly Drinker
9.170000E-01
Daily Drinker-vs-Occasional Drinker
1.259420E-01
Daily Drinker-vs-Social Drinker
2.697400E-01
Weekly Drinker-vs-Occasional Drinker
7.987800E-02
Weekly Drinker-vs-Social Drinker
2.580000E-01
Occasional Drinker-vs-Social Drinker
8.803200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.561000E-01
Normal-vs-Grade 2
1.067190E-01
Normal-vs-Grade 3
1.051800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.253900E-02
Grade 1-vs-Grade 3
1.556380E-02
Grade 1-vs-Grade 4
2.561000E-01
Grade 2-vs-Grade 3
5.700600E-01
Grade 2-vs-Grade 4
1.067190E-01
Grade 3-vs-Grade 4
1.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.009000E-01
Normal-vs-NonDiabetic
8.228000E-01
Diabetic-vs-NonDiabetic
2.905000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.734000E-02
Normal-vs-NoPancreatitis
8.051600E-01
Pancreatitis-vs-NoPancreatitis
1.073870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.422000E-01
Normal-vs-N1
4.239600E-01
N0-vs-N1
8.196500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.538600E-01
Normal-vs-TP53-NonMutant
6.268000E-01
TP53-Mutant-vs-TP53-NonMutant
6.571900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
